These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 26863344

  • 1. BRAF analysis before surgery for papillary thyroid carcinoma: correlation with clinicopathological features and prognosis in a single-institution prospective experience.
    Galuppini F, Pennelli G, Vianello F, Censi S, Zambonin L, Watutantrige-Fernando S, Manso J, Nacamulli D, Lora O, Pelizzo MR, Rugge M, Barollo S, Mian C.
    Clin Chem Lab Med; 2016 Sep 01; 54(9):1531-9. PubMed ID: 26863344
    [Abstract] [Full Text] [Related]

  • 2. BRAF mutation analysis of fine-needle aspiration biopsies of papillary thyroid carcinoma: impact on diagnosis and prognosis.
    Colanta A, Lin O, Tafe L, Ghossein R, Nafa K, Mitchell T, Ladanyi M, Arcila M.
    Acta Cytol; 2011 Sep 01; 55(6):563-9. PubMed ID: 22156467
    [Abstract] [Full Text] [Related]

  • 3. BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience.
    Pelizzo MR, Boschin IM, Barollo S, Pennelli G, Toniato A, Zambonin L, Vianello F, Piotto A, Ide EC, Pagetta C, Sorgato N, Torresan F, Girelli ME, Nacamulli D, Mantero F, Mian C.
    Clin Chem Lab Med; 2011 Feb 01; 49(2):325-9. PubMed ID: 21175381
    [Abstract] [Full Text] [Related]

  • 4. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.
    Zhao H, Zhang ZH, Zhou B, Xiao T, Pan QJ, Guo HQ.
    Diagn Cytopathol; 2015 Oct 01; 43(10):786-90. PubMed ID: 26152656
    [Abstract] [Full Text] [Related]

  • 5. Cytomorphological factors and BRAF mutation predicting risk of lymph node metastasis in preoperative liquid-based fine needle aspirations of papillary thyroid carcinoma.
    Chung SY, Lee JS, Lee H, Park SH, Kim SJ, Ryu HS.
    Acta Cytol; 2013 Oct 01; 57(3):252-8. PubMed ID: 23636013
    [Abstract] [Full Text] [Related]

  • 6. BRAF mutation in fine-needle aspiration specimens as a potential predictor for persistence/recurrence in patients with classical papillary thyroid carcinoma larger than 10 mm at a BRAF mutation prevalent area.
    Moon HJ, Kim EK, Chung WY, Shin DY, Kwak JY.
    Head Neck; 2015 Oct 01; 37(10):1432-8. PubMed ID: 24838814
    [Abstract] [Full Text] [Related]

  • 7. BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance.
    Adeniran AJ, Hui P, Chhieng DC, Prasad ML, Schofield K, Theoharis C.
    Acta Cytol; 2011 Oct 01; 55(6):570-5. PubMed ID: 22156468
    [Abstract] [Full Text] [Related]

  • 8. Surgical perspective of T1799A BRAF mutation diagnostic value in papillary thyroid carcinoma.
    Brahma B, Yulian ED, Ramli M, Setianingsih I, Gautama W, Brahma P, Sastroasmoro S, Harimurti K.
    Asian Pac J Cancer Prev; 2013 Oct 01; 14(1):31-7. PubMed ID: 23534744
    [Abstract] [Full Text] [Related]

  • 9. Role of BRAF V600E mutation as an indicator of the extent of thyroidectomy and lymph node dissection in conventional papillary thyroid carcinoma.
    Kim SK, Woo JW, Lee JH, Park I, Choe JH, Kim JH, Kim JS.
    Surgery; 2015 Dec 01; 158(6):1500-11. PubMed ID: 26120069
    [Abstract] [Full Text] [Related]

  • 10. BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer.
    Xing M, Clark D, Guan H, Ji M, Dackiw A, Carson KA, Kim M, Tufaro A, Ladenson P, Zeiger M, Tufano R.
    J Clin Oncol; 2009 Jun 20; 27(18):2977-82. PubMed ID: 19414674
    [Abstract] [Full Text] [Related]

  • 11. Lack of association of BRAF mutation with negative prognostic indicators in papillary thyroid carcinoma: the University of California, San Francisco, experience.
    Gouveia C, Can NT, Bostrom A, Grenert JP, van Zante A, Orloff LA.
    JAMA Otolaryngol Head Neck Surg; 2013 Nov 20; 139(11):1164-70. PubMed ID: 24030686
    [Abstract] [Full Text] [Related]

  • 12. Correlation among the BRAF gene mutation status, clinicopathological features of primary tumour, and lymph node metastasizing of papillary thyroid carcinoma.
    Lukas J, Drabek J, Dudesek B, Vazan P, Stranska J, Jancik S, Mackova M, Syrucek M, Lukas D, Duskova J, Dundr P, Hintnausova B, Jiskra J.
    Exp Clin Endocrinol Diabetes; 2014 May 20; 122(5):268-72. PubMed ID: 24839220
    [Abstract] [Full Text] [Related]

  • 13. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
    Shi C, Guo Y, Lv Y, Nanding A, Shi T, Qin H, He J.
    PLoS One; 2016 May 20; 11(12):e0167414. PubMed ID: 27936049
    [Abstract] [Full Text] [Related]

  • 14. Use of BRAF v600e immunocytochemistry on FNA direct smears of papillary thyroid carcinoma.
    Wobker SE, Kim LT, Hackman TG, Dodd LG.
    Cancer Cytopathol; 2015 Sep 20; 123(9):531-9. PubMed ID: 26080065
    [Abstract] [Full Text] [Related]

  • 15. Mutant-specific BRAF and CD117 immunocytochemistry potentially facilitate risk stratification for papillary thyroid carcinoma in fine-needle aspiration biopsy specimens.
    Meng Z, Lu J, Wu H, Zhao Y, Luo Y, Gao J, Zhu Q, Jiang Y, Li W, Liang Z.
    Tumour Biol; 2016 Jan 20; 37(1):611-8. PubMed ID: 26240026
    [Abstract] [Full Text] [Related]

  • 16. Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma".
    Jara SM, Bhatnagar R, Guan H, Gocke CD, Ali SZ, Tufano RP.
    Head Neck; 2015 Dec 20; 37(12):1788-93. PubMed ID: 24989827
    [Abstract] [Full Text] [Related]

  • 17. The role of BRAF(V600E) mutation as poor prognostic factor for the outcome of patients with intrathyroid papillary thyroid carcinoma.
    Pelizzo MR, Dobrinja C, Casal Ide E, Zane M, Lora O, Toniato A, Mian C, Barollo S, Izuzquiza M, Guerrini J, De Manzini N, Merante Boschin I, Rubello D.
    Biomed Pharmacother; 2014 May 20; 68(4):413-7. PubMed ID: 24721322
    [Abstract] [Full Text] [Related]

  • 18. The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study.
    Elisei R, Viola D, Torregrossa L, Giannini R, Romei C, Ugolini C, Molinaro E, Agate L, Biagini A, Lupi C, Valerio L, Materazzi G, Miccoli P, Piaggi P, Pinchera A, Vitti P, Basolo F.
    J Clin Endocrinol Metab; 2012 Dec 20; 97(12):4390-8. PubMed ID: 23066120
    [Abstract] [Full Text] [Related]

  • 19. Value of immunohistochemistry in the detection of BRAF(V600E) mutations in fine-needle aspiration biopsies of papillary thyroid carcinoma.
    Zimmermann AK, Camenisch U, Rechsteiner MP, Bode-Lesniewska B, Rössle M.
    Cancer Cytopathol; 2014 Jan 20; 122(1):48-58. PubMed ID: 24039206
    [Abstract] [Full Text] [Related]

  • 20. Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study.
    Adeniran AJ, Theoharis C, Hui P, Prasad ML, Hammers L, Carling T, Udelsman R, Chhieng DC.
    Thyroid; 2011 Jul 20; 21(7):717-23. PubMed ID: 21568726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.